Literature DB >> 9177352

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis.

T Yokomizo1, T Izumi, K Chang, Y Takuwa, T Shimizu.   

Abstract

Leukotriene B4 (LTB4) is a potent chemoattractant that is primarily involved in inflammation, immune responses and host defence against infection. LTB4 activates inflammatory cells by binding to its cell-surface receptor (BLTR). LTB4 can also bind and activate the intranudear transcription factor PPAR alpha, resulting in the activation of genes that terminate inflammatory processes. Here we report the cloning of the complementary DNA encoding a cell-surface LTB4 receptor that is highly expressed in human leukocytes. Using a subtraction strategy, we isolated two cDNA clones (HL-1 and HL-5) from retinoic acid-differentiated HL-60 cells. These two clones contain identical open reading frames encoding a protein of 352 amino acids and predicted to contain seven membrane-spanning domains, but different 5'-untranslated regions. Membrane fractions of Cos-7 cells transfected with an expression construct containing the open reading frame of HL-5 showed specific LTB4 binding, with a K(d) (0.154nM) comparable to that observed in retinoic acid-differentiated HL-60 cells. In CHO cells stably expressing this receptor, LTB4 induced increases in intracellular calcium, D-myo-inositol-1,4,5-triphosphate (InsP3) accumulation, and inhibition of adenylyl cyclase. Furthermore, CHO cells expressing exogenous BLTR showed marked chemotactic responses towards low concentrations of LTB4 in a pertussis-toxin-sensitive manner. Our findings, together with previous reports, show that LTB4 is a unique lipid mediator that interacts with both cell-surface and nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177352     DOI: 10.1038/42506

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  223 in total

1.  Protein-assisted pericyclic reactions: an alternate hypothesis for the action of quantal receptors.

Authors:  W Radding; T Romo; G N Phillips
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells.

Authors:  R Janssens; J M Boeynaems
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 3.  Leukotriene receptors.

Authors:  S E Dahlén
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 4.  Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis.

Authors:  J Z Haeggström
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

5.  An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury.

Authors:  E Noiri; T Yokomizo; A Nakao; T Izumi; T Fujita; S Kimura; T Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

6.  Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors.

Authors:  S Honda; Y Sasaki; K Ohsawa; Y Imai; Y Nakamura; K Inoue; S Kohsaka
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

7.  Mirror orientation selection (MOS): a method for eliminating false positive clones from libraries generated by suppression subtractive hybridization.

Authors:  D V Rebrikov; O V Britanova; N G Gurskaya; K A Lukyanov; V S Tarabykin; S A Lukyanov
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

8.  The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals.

Authors:  T Okabe; M Hide; O Koro; N Nimi; S Yamamoto
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

Review 9.  Anti-leukotrienes in asthma: yet to arrive.

Authors:  G Gupta
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

Review 10.  Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Authors:  Magnus Bäck; William S Powell; Sven-Erik Dahlén; Jeffrey M Drazen; Jilly F Evans; Charles N Serhan; Takao Shimizu; Takehiko Yokomizo; G Enrico Rovati
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.